Literature DB >> 2847931

Burkitt's lymphoma cell lines producing truncated mu immunoglobulin heavy chains lacking part of the variable region.

M Cogné1, S Mounir, J L Preud'homme, F Nau, P Guglielmi.   

Abstract

Burkitt's lymphoma cell lines Ly91, Ly47 and JBL2 contained intracytoplasmic mu chains without light chains and variably expressed membrane mu chains. All three cell lines produced similarly truncated heavy chains with an apparent molecular mass of 64 kDa instead of the normal 74 kDa. Both the intracellular and secreted forms of the mu chains were similarly truncated. The membrane and the secreted forms of mu mRNAs were shorter than normal. The cDNAs contained a leader sequence, followed by about one third of a variable region (VH), then by the constant region (C mu). Interruption of the variable region took place near the end of the framework region 1 (FR 1) in Ly 47 and JBL2, and within the complementarity determining region 1 (CDR1) in Ly91. In the three lines, the joining between VH and C mu maintained the normal open reading frame throughout the variable and constant regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847931     DOI: 10.1002/eji.1830181003

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Structure and expression of the mb-1 transcript in human lymphoid cells.

Authors:  I Leduc; J L Preud'homme; M Cogné
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Molecular cloning and nucleotide sequence of a cDNA encoding hydroxyindole O-methyltransferase from chicken pineal gland.

Authors:  P Voisin; J Guerlotté; M Bernard; J P Collin; M Cogné
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.